A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.

Clinical journal of the American Society of Nephrology : CJASN

Volumn 1, Issue 1, 2006, Pages 109-116

  Tumlin, James A ^a   Miller, Danlyn ^a   Near, Mitzi ^a   Selvaraj, Sasi ^a   Hennigar, Randolph ^a   Guasch, Antonio ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; MALE; PROSPECTIVE STUDY;

ADULT; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PROSPECTIVE STUDIES; SIROLIMUS;

EID: 33745584227     PISSN: None     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00120605     Document Type: Article

References (0)